Newsletter | August 28, 2025

08.28.25 -- Find Small Molecule CDMOs With Available Capacity

Considering outsourcing development and manufacturing? The Outsourced Pharma Capacity Update (OPCU), a free, interactive, digital event, convenes the industry's foremost CDMOs to provide up-to-date and direct insights into their available capacity and services, alongside specific facility and equipment updates. 

 

Discover the July 2025 event’s presenting sponsors in this newsletter to learn how they are best suited to help you to navigate the path to approval and commercialization.

SMALL MOLECULE API & HPAPI DEVELOPMENT

Aragen

Explore specialized expertise in solving challenging small molecule formulation problems (poor solubility, bioavailability, complex delivery routes).

Request Information

Aragen

MilliporeSigma

Applications specialist John Stevens shows how MilliporeSigma is using their 35+ years of CDMO experience and expertise to move small molecules forward to the clinic and to commercialization.

Request Information

MilliporeSigma

Grace Fine Chemical Manufacturing Services

With capabilities to support your next small molecule drug substance program from R&D to commercial scale, learn about integrated facilities, project teams, and available capacity.

Request Information

Grace Fine Chemical Manufacturing Services

Lonza

ASDs are an attractive option for progressing and commercializing poorly soluble compounds. Find capabilities to screen the potential for ASDs in early phase studies and their commercial applicability.

Request Information

Lonza

ADC

MilliporeSigma

With more than 15 years of experience as conjugation and linker-payload CDMO, MilliporeSigma has a proven track record of supporting clinical programs from IND to PPQ for commercialization.

Request Information

MilliporeSigma

Lonza

Leveraging Lonza's deep ADC expertise and experience, successfully develop high quality, commercially viable processes, spanning from pre-clinical development through commercial scale manufacturing.

Request Information

Lonza

Simtra BioPharma Solutions

With more than 65 years of sterile injectable manufacturing experience, Simtra offers world-class GMP sterile fill/finish services, deep scientific and technical expertise, and a uniquely collaborative approach.

Request Information

Simtra BioPharma Solutions

SMALL MOLECULE FINISHED DOSAGE FORM

Quotient Sciences

Compressed timelines pose challenges, ranging from limited API supply to clinical trial logistics. Expedited review pathways can be used to accelerate development while mitigating CMC risks.

Request Information

Quotient Sciences

Douglas CDMO

Lora Wallis and Chris Cuthbertson highlight Douglas CDMO’s strengths in high-potency softgels and liquids and the company's 67 years of expertise and a client-centric approach.

Request Information

Douglas CDMO

PCI Pharma Services

Dr. Rebecca Coutts highlights PCI’s high potent oral solid dose (OSD) and oral liquid capabilities, focusing on site expertise, specialized infrastructure, and handling of complex molecules.

Request Information

PCI Pharma Services

Upperton Pharma Solutions

Ian Lafferty, CTO, and Josh Moule, Business Development Manager, talk through Upperton’s capabilities and project management approach. See a virtual tour of their development and manufacturing facility.

Request Information

Upperton Pharma Solutions

Bora Pharmaceuticals

Bora Pharmaceuticals specializes in formulation development, clinical and commercial manufacturing, and packaging of complex oral solid dose, liquid, semi-solid, and sterile injectable products.

Request Information

Bora Pharmaceuticals

EVENT REGISTRATION

Streamline your search for the ideal CDMO partner at the October 2025 OPCU virtual event! Ease the burden of a prolonged vetting process by connecting with multiple CDMOs to find the best partner for your project while getting an inside look at their capabilities and capacities.

 

Monday, October 6: Analytical Services

Monday, October 6: ADC

Tuesday, October 7: Large Molecule

Wednesday, October 8: Small Molecule Drug Substance/API

Wednesday, October 8: Small Molecule Drug Product/Finished Dosage Form

Thursday, October 9: Cell & Gene Therapy

Friday, October 10: Fill/Finish